Journal of Clinical Respiratory Medicine

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Journal of Clinical Respiratory Medicine 44 7897 074717

Review Article - Journal of Clinical Respiratory Medicine (2025) Volume 9, Issue 4

Ards and sepsis: Evolving ventilation, care, recovery.revi

Lucas Pereira*

Department of Clinical Medicine, University of São Paulo, Brazil

*Corresponding Author:
Lucas Pereira
Department of Clinical Medicine
University of São Paulo, Brazil.
E-mail: lucas.pereira@usp.br

Received : 01-Jul-2025, Manuscript No. AAJCRM-25-280; Editor assigned : 03-Jul-2025, PreQC No. AAJCRM-25-280(PQ); Reviewed : 23-Jul-2025, QC No AAJCRM-25-280; Revised : 01-Aug-2025, Manuscript No. AAJCRM-25-280(R); Published : 12-Aug-2025 , DOI : 10.35841/AAJCRM-9.4.280

Citation: Pereira L. Ards and sepsis: Evolving ventilation, care, recovery. J Clin Resp Med. 2025;09(04):280.

Visit for more related articles at Journal of Clinical Respiratory Medicine

Introduction

Acute Respiratory Distress Syndrome (ARDS) and sepsis represent critical conditions in intensive care, demanding sophisticated management strategies. Current understanding of ARDS encompasses its complex pathophysiology, marked by widespread inflammation and compromised gas exchange. Established management principles, like lung-protective ventilation and fluid management, form the foundation, with a growing focus on emerging therapies and individualized approaches that indicate a move towards more tailored treatments [2].

Mechanical ventilation is a cornerstone in managing ARDS, especially when caused by sepsis. This involves implementing lung-protective strategies such as low tidal volume and appropriate Positive End-Expiratory Pressure (PEEP), crucial for reducing lung injury. Beyond these established methods, emerging approaches like personalized ventilation and advanced monitoring are gaining traction. The goal is to optimize patient outcomes by adjusting ventilation based on individual physiological responses in this critically ill population [1].

However, mechanical ventilation is not without risks. The mechanisms leading to Ventilator-Induced Lung Injury (VILI) in ARDS patients are well-documented, explaining how excessive mechanical stress can worsen lung damage. Various forms of VILI, including volutrauma and barotrauma, necessitate careful consideration. Strategies to lessen these risks concentrate on fine-tuning ventilation parameters like tidal volume and PEEP, ultimately protecting the injured lung and improving patient prognosis [4].

In response, the concept of personalized mechanical ventilation in ARDS is being explored, evaluating evidence for customizing ventilatory settings to an individual's physiology. Techniques such as lung imaging, esophageal pressure monitoring, and advanced physiological assessments help identify optimal PEEP and tidal volume strategies. This aims to enhance lung protection and clinical outcomes, moving beyond generic ventilatory approaches [5].

For severe cases where conventional mechanical ventilation proves insufficient, Extracorporeal Membrane Oxygenation (ECMO) acts as a vital rescue therapy. This advanced life support system requires careful consideration of indications, patient selection, and potential complications, highlighting the necessity for specialized centers and multidisciplinary teams. Current evidence and ongoing trials continue to clarify ECMO's impact on patient outcomes [7].

Once patients stabilize, guidelines offer evidence-based recommendations for weaning adults from mechanical ventilation. This critical recovery phase for ARDS or sepsis patients involves systematic approaches for readiness assessment, spontaneous breathing trials, and managing common challenges, with the objective of reducing ventilation duration and associated complications [8].

Sepsis itself presents ongoing challenges, stemming from an evolving understanding of its complex pathophysiology, which includes dysregulated immune responses and organ dysfunction. The limitations of current therapies are prompting exploration into promising new avenues, such as immune modulators and personalized approaches, to improve outcomes in this diverse syndrome [6].

To standardize care and enhance patient outcomes, international guidelines for managing sepsis and septic shock, like those from 2021, provide practical recommendations. These cover initial resuscitation, antibiotic therapy, vasopressor use, and ventilation strategies, emphasizing early recognition and prompt, evidence-based intervention [3].

Bridging research and clinical application, the role of various biomarkers in the diagnosis, prognosis, and therapeutic guidance of sepsis and ARDS is under investigation. Both established and novel candidates, which reflect inflammation, endothelial damage, and organ dysfunction, are reviewed. The discussion points to the potential of these biomarkers to personalize management strategies and improve risk stratification [9].

Finally, attention is also given to the significant long-term consequences faced by survivors of ARDS, particularly those requiring mechanical ventilation. Common impairments, including persistent physical weakness, cognitive dysfunction, and psychological distress, underline the need for comprehensive post-Intensive Care Unit (ICU) care and rehabilitation programs to enhance quality of life and functional recovery for these patients [10].

 

Conclusion

This collection of articles offers a comprehensive look at the multifaceted challenges and evolving strategies in managing Acute Respiratory Distress Syndrome (ARDS) and sepsis. It highlights the critical role of mechanical ventilation, detailing established lung-protective strategies such as low tidal volume and appropriate PEEP to minimize Ventilator-Induced Lung Injury (VILI), which includes volutrauma and barotrauma. The literature also emphasizes a shift towards personalized ventilation, using advanced monitoring and techniques like lung imaging and esophageal pressure monitoring to tailor settings to individual patient physiology for improved outcomes. Beyond conventional ventilation, Extracorporeal Membrane Oxygenation (ECMO) emerges as a crucial rescue therapy for severe ARDS when standard methods fail, underscoring the need for specialized centers. The papers also address broader aspects of sepsis and ARDS care. International guidelines for sepsis and septic shock provide standardized recommendations for early recognition, resuscitation, antibiotic therapy, and vasopressor use. Understanding the complex pathophysiology of both conditions, involving widespread inflammation, impaired gas exchange, and dysregulated immune responses, is key to developing effective therapies. Emerging approaches in sepsis management explore immune modulators and further personalized treatments. Furthermore, the role of various biomarkers in diagnosis, prognosis, and guiding therapy for sepsis and ARDS is discussed, aiming to bridge research with clinical practice for better risk stratification. Finally, the long-term physical, cognitive, and psychological consequences faced by ARDS survivors are brought to light, emphasizing the necessity of post-ICU rehabilitation to enhance their quality of life.

References

References

    1. Laurent JB, Arthur SS, V. MR. Mechanical Ventilation for Sepsis-Induced ARDS: A Review of Current and Emerging Strategies. Semin Respir Crit Care Med. 2020;41(6):791-802.

Indexed at, Google Scholar, Crossref

    1. Giacomo B, Gennaro DP, Paolo P. Acute Respiratory Distress Syndrome: Current Knowledge and Future Perspectives. Crit Care. 2020;24(1):367.

Indexed at, Google Scholar, Crossref

    1. Laura E, Waleed A, Massimiliano A. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Crit Care Med. 2021;49(11):e1063-e1143.

Indexed at, Google Scholar, Crossref

    1. Marcelo GdA, Paolo P, Burkhard L. Mechanisms and management of ventilator-induced lung injury in ARDS. Intensive Care Med Exp. 2020;8(1):57.

Indexed at, Google Scholar, Crossref

    1. Samir J, Jean-Pierre F, Antoine K. Personalized mechanical ventilation in ARDS: what is the current evidence?. Crit Care. 2020;24(1):116.

Indexed at, Google Scholar, Crossref

    1. Mervyn S, Daniel DB, Richard SH. Sepsis: current challenges and future directions. Lancet Respir Med. 2021;9(2):161-172.

Indexed at, Google Scholar, Crossref

    1. Alain C, Daniel B, Eddy F. Extracorporeal membrane oxygenation for acute respiratory distress syndrome. Lancet Respir Med. 2020;8(8):752-766.

Indexed at, Google Scholar, Crossref

    1. Waleed A, Tyler JW, Maureen OM. Weaning from mechanical ventilation in adults: A clinical practice guideline. Crit Care Med. 2019;47(2):297-302.

Indexed at, Google Scholar, Crossref

    1. Jesús B, Rosa MS, Carlos CB. Biomarkers in Sepsis and Acute Respiratory Distress Syndrome: From Research to Clinical Practice. J Clin Med. 2021;10(15):3373.

Indexed at, Google Scholar, Crossref

    1. Fan Z, Xiaomin Z, Yanjie X. Long-term outcomes of acute respiratory distress syndrome survivors: a systematic review and meta-analysis. Crit Care. 2020;24(1):167.

Indexed at, Google Scholar, Crossref

Get the App